New research reveals that people who come off blockbuster slimming jabs like Mounjaro or Wegovy can put back on reduced body mass at a significantly accelerated pace than those who stop conventional lifestyle programs.
Research printed in a prominent medical journal demonstrates that while overweight individuals frequently drop substantial amounts of their body weight while on the medication, the mass comes back at an average rate of 0.8 kg per month once they quit.
"Individuals buying such drugs need to be informed of the risk of fast rebound weight gain when the medication is stopped," warns researcher Dr. Susan Jebb.
That rate of regain means a reversion to original mass within about a year and a half.
Comparing Therapies
The analysis, which looked at 37 of studies involving thousands of participants, compared the outcomes of the injectable medications with other pills.
Scientists note that people who lose weight through dieting generally experience a slower weight regain—perhaps 100 grams monthly—once they finish.
The Reason for the Fast Rebound
Experts believe the way of the injections explains the heightened weight return.
These medications copy a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.
"Artificially providing the hormone concentrations several times higher than the body's typical production may cause the system to generate a reduced amount of its endogenous hormone, and may also diminish sensitivity to its actions," noted Dr. Adam Collins, a nutrition expert.
"Withdrawal of this hormone supplement means appetite is uncontrolled, making excessive eating much more probable."
A Lifelong Disease?
The NHS recommend the injections for individuals with weight-linked health risks, alongside recommended lifestyle changes.
A number of clinicians contend that, given the significant potential of relapse, the treatment should be considered life-long.
This opinion is reinforced by drug manufacturers, who note that the findings "underscore the long-term character of obesity," akin to managing conditions like diabetes.
User Experiences
Individuals who have discontinued the jabs describe a intense return of appetite.
"I experienced a switch activating and I was suddenly starving," said an individual.
The struggle is worsened if users have not adopted sustainable lifestyle or habit changes during therapy.
Significant Adoption
Recent estimates indicate that millions of people in the UK have tried these injections in the past year, with demand continuing to grow.
- Adoption is more common among females compared to men.
- The 40s and 50s demographic shows the highest level of interest.
- A large proportion obtain the medications through private healthcare rather than public health services.
In conclusion, experts emphasize that while the jabs are potent tools for shedding pounds, they are not a standalone fix and lasting health benefits relies on ongoing behavioural management.
